TACI mutations and disease susceptibility in patients with common variable immunodeficiency

A. E. J. Poodt, G. J. A. Driessen, A. de Klein, J. J. M. van Dongen, M. van der Burg, E. de Vries*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

41 Citations (Scopus)

Abstract

The most prevalent primary immunodeficiency is common variable immunodeficiency (CVID). Mutations have been described in four genes, ICOS, CD19, BAFF-R and TNFRSF13B (encoding TACI), together associated with 10-15% of CVID cases. We investigated a family with CVID and identified the heterozygous C104R TNFRSF13B mutation in two of the three index-children with CVID, a mother with selective immunoglobulin A deficiency, a mother with recurrent infections and a healthy grandfather. Remarkably, we did not find the TNFRSF13B mutation in the third index-child with CVID, despite his hypogammaglobulinaemia and decreased response to unconjugated pneumococcal vaccine. This family illustrates that TNFRSF13B mutations induce disease susceptibility rather than cause disease directly. Apparently, other genetic or environmental factors, still to be identified, contributed to the development of CVID in this family. Consequently, TNFRSF13B mutations must be interpreted with caution in the clinical setting.

Original languageEnglish
Pages (from-to)35-39
Number of pages5
JournalClinical and Experimental Immunology
Volume156
Issue number1
DOIs
Publication statusPublished - Apr-2009

Keywords

  • common variable immunodeficiency
  • primary immunodeficiency
  • TNFRSF13B gene
  • transmembrane activator and CAML interactor protein
  • DIPHTHERIA ANTITOXIN
  • IGA DEFICIENCY
  • ICOS

Fingerprint

Dive into the research topics of 'TACI mutations and disease susceptibility in patients with common variable immunodeficiency'. Together they form a unique fingerprint.

Cite this